Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Sardines have been explored as a dietary component potentially beneficial in the support and prevention of Alzheimer's Disease, largely due to their high content of omega-3 fatty acids, particularly eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). Scientific studies have shown that DHA, in particular, is crucial for maintaining neuronal membrane fluidity and function. Several observational studies have found associations between higher fish consumption and a reduced risk of cognitive decline and Alzheimer’s Disease. For example, a 2016 review in the journal Frontiers in Aging Neuroscience noted that regular consumption of fish, such as sardines, was correlated with a lower incidence of Alzheimer's. Additionally, omega-3 supplementation has been shown to have modest benefits in slowing cognitive decline in some individuals with mild cognitive impairment, though results in established Alzheimer’s Disease are less consistent.

However, the direct evidence for sardines specifically (as opposed to general fish or omega-3 supplements) is limited. Clinical trials focusing on omega-3 supplementation often use purified fish oils rather than whole food sources like sardines. Furthermore, large-scale intervention studies in patients with Alzheimer’s Disease have yielded mixed results, with some showing benefit and others not demonstrating significant effects. Thus, while there is a scientific rationale and some supportive epidemiological evidence, sardines should be considered part of a generally healthy diet rather than a standalone treatment for Alzheimer’s Disease.

More about sardines
More about Alzheimer's Disease

Other ingredients used for Alzheimer's Disease

Other health conditions supported by sardines

Products containing sardines